JUDY DE LA VEGA: Open Payments
NPI 1376242644 · SPANISH FORK, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 40 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $294 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $438 |
| Organon LLC | 5 | $50 |
| Astellas Pharma US Inc | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| PFIZER INC. | 1 | $14 |
Products named: QULIPTA, VRAYLAR, NEXPLANON, Veozah, REXULTI, MAVYRET, MOUNJARO, CAPLYTA.
Industry payments across UT — which companies pay providers there.
